P
olyketide synthases (PKSs) are multienzymes that underlie the biosynthesis of potent bioactive compounds such as antibiotics or toxins 1 . Their product diversity is generated by the sequential action of PKS modules, each responsible for polyketide elongation by condensation of acyl building blocks and subsequent reduction and further modification. Homodimeric PKS modules are organized into a mandatory-condensing and an optional-modifying region [2] [3] [4] [5] and integrate acyl carrier proteins (ACPs) for shuttling covalently tethered intermediates. Condensing regions consist of an acyltransferase (AT) domain and a ketosynthase (KS) domain. The AT is responsible for loading acyl-CoA-derived extender units onto the phosphopantetheine (Ppant)-modified holo-ACP, whereas the KS catalyzes the elongation of a polyketide precursor by decarboxylative Claisen condensation with the ACP-bound acyl extender unit. Modifying regions contain up to three canonical types of domains, the ketoreductase (KR), the dehydratase (DH), and the enoyl-reductase (ER), which sequentially modify the β -keto position of the KS condensation product. In the presence of all three canonical modifying domains (KR, DH, and ER), a fully saturated product is generated, whereas in non-or partially reducing modules various combinations of the modifying domains can maintain the β -keto group or optionally reduce or dehydrate it to a hydroxyl, alkene, or alkane. PKS modules act either iteratively (iPKS) or sequentially with directed substrate transfer between linked modules in multimodular assembly lines (modPKS). Specialized loading modules or domains act as gatekeepers and initiate polyketide synthesis by starter unit loading 6 . Iterative nonreducing (NR)-PKSs, which have reducing modifying domains, elongate successive poly-β -ketone intermediates until a final length-determined by the KS-is reached 7 . The nonreduced polyketide is cyclized by a product template (PT) domain to form an aromatic or fused aromatic ring system that is released from the ACP by a thioesterase (TE). In NR-PKSs, biosynthesis is initiated by starter unit acyltransferase (SAT) domains, which load the ACP with acyl starter units obtained from coenzyme A (CoA) thioesters or from ACPs of other multienzymes 8, 9 . The ACP transfers the starter unit to the active site cysteine of the KS and then the Ppant arm of the ACP is charged with a malonyl extender unit by a malonyl-CoAspecific acyl-transferase (MAT) in all subsequent elongation cycles. NR-PKSs share a common architecture and conserved interdomain interactions as demonstrated by functional domain swaps of ACPs, PTs, and loading/condensing regions (SAT-KS-MAT) of homologous enzymes in deconstruction experiments 7, 10 . In some NR-PKSs, ACPs occur as functionally equivalent tandem didomains 10, 11 . PKSs are dimeric multienzymes with structural segregation of condensing and modifying regions 2, 12 , similar to the mammalian fatty acid synthase (mFAS) 5 . However, the structural integration of dedicated loading modules or specialized substrate-loading domains, as exemplified by the NR-PKS SAT-KS-MAT core region, remains unknown. The KS-MAT didomains of NR-PKSs are homologs of the corresponding condensing regions in other PKSs and mFAS, which have been structurally characterized as isolated didomains 2, 4, 5, [13] [14] [15] . However, in NR-PKSs, soluble expression of KS-MAT is only achieved by including the SAT domain in a tridomain construct 16, 17 , indicating that SAT, KS, and MAT form an integrated loading/condensing region architecture. SATs can be successfully isolated 18 and swapped in the context of the condensing region environment 19 . Together with an ACP, the SAT-KS-MAT core region of NR-PKSs is catalytically competent for synthesis of the complete polyketide backbone in vitro 7, 10, 17 . Early crosslinking experiments demonstrated binding of NR-PKS ACP domains to the dimeric KS preferentially with a 1:2 stoichiometry 20 .
To study PKS substrate-loading architectures and the organization of NR-PKSs, we focused on the SAT-KS-MAT loading/condensing region of the NR-PKS CTB1. CTB1 produces nor-toralactone, the aromatic polyketide precursor to cercosporin in the fungus Cercospora nicotianae 21, 22 (Fig. 1 ). Cercosporin is a lightactivated plant toxin and protein kinase C inhibitor essential for C. nicotianae infectivity 23 . CTB1 contains five enzymatic domains as well as tandem ACPs (ACP1-ACP2). For initiation of CTB1 biosynthesis, acetyl-CoA is loaded via the SAT 6 onto an ACP and transferred to the KS. The iterative action of the KS-MAT condensing region Polyketide production is initiated by the loading of a starter unit onto an integral acyl carrier protein (ACP) and its subsequent transfer to the ketosynthase (KS). Initial substrate loading is achieved either by multidomain loading modules or by the integration of designated loading domains, such as starter unit acyltransferases (SAT), whose structural integration into PKS remains unresolved. A crystal structure of the loading/condensing region of the nonreducing PKS CTB1 demonstrates the ordered insertion of a pseudodimeric SAT into the condensing region, which is aided by the SAT-KS linker. Cryo-electron microscopy of the post-loading state trapped by mechanism-based crosslinking of ACP to KS reveals asymmetry across the CTB1 loading/-condensing region, in accord with preferential 1:2 binding stoichiometry. These results are critical for re-engineering the loading step in polyketide biosynthesis and support functional relevance of asymmetric conformations of PKSs.
produces an ACP-tethered heptaketide (C14), which is subsequently cyclized by the PT and released as a pyrone by the TE 24 ( Fig. 1 ). Here we report the crystal structure of the CTB1 SAT-KS-MAT region, which reveals a pseudodimeric arrangement of SAT domains nested in a cleft formed by the KS and MAT domains. To specifically resolve the transient interactions in the substrate-loading step, we employed mechanism-based crosslinking 25 to trap a functional state of an ACP-KS interaction for cryo-electron microscopy (EM) structure determination.
Results
Crystal structure of an integrated loading architecture. The 2.8-Å resolution crystal structure of SAT-KS-MAT reveals a compact dimer of rhomboid shape ( Fig. 2 ; Supplementary Table 1; Supplementary  Fig. 1 ). The two KS domains dimerize, and each monomer of the KS laterally connects to one MAT through a small linker domain (LD). The individual domain structures (Supplementary Table 2a ) and the overall arrangement of the KS-LD-MAT domains (Fig. 2a,b ) resemble condensing-region structures from mFAS 5, 15 , fully-reducing iPKS 2 and several modPKS 4, 13, 14 , but differ from the architecture of the PikAIII modPKS that was resolved at intermediate resolution by cryo-EM 12, 26 (Supplementary Fig. 2 ). The SAT has structural homology with other ATs, with r.m.s. deviations of C α atom positions between 2.5-3.2 Å for 62-75% aligned amino acids (aa) (Supplementary Table 2a ) and an active site located in a cleft between the α /β -hydrolase core fold and a ferredoxin-like subdomain. The C terminus of the SAT domain is connected via a 26-aa linker to the N terminus of the KS domain (Fig. 2c) . Nine aa of this linker remain disordered in the crystal structure, but the connectivity is unambiguously determined on the basis of maximal linker length and spatial restraints (Fig. 2c) . In an intertwined arrangement, the SAT domain linked to the KS of the first protomer is nested by the KS-LD-MAT domains of the second protomer (Fig. 2a) . The clefts formed between the MAT and KS domains, which have been suggested to guide the interactions of the upstream ACP with the KS in modPKSs 27 , are partially occupied by the SAT domains. The active site entrance of each SAT domain points into this cleft toward the other protomer's KS active site, which is located at a distance of 56 Å.
The arrangement of the two SAT domains is stabilized by interfaces with surrounding domains (Fig. 2d and Supplementary Fig. 3a) . The two SAT domains form a direct pseudodimer interface of 324 Å 2 that is devoid of hydrogen bonds or salt bridges (Supplementary  Table 2b and Supplementary Fig. 3b,c) . The C-terminal end of the SAT-KS linker adds an average interface area of 493 Å 2 by binding to a surface groove of the opposite SAT ( Fig. 2c and Supplementary  Table 2b ). The largest interface with the highest predicted stability is the one formed between the SAT and MAT of opposite chains, covering an average of 957 Å 2 ( Fig. 2d and Supplementary Fig. 3d ,e) and a network of at least two salt bridges and five hydrogen bonds. The interface of the SAT domain to the other protomer's KS domain is considerably smaller (184 Å 2 ; Supplementary Fig. 3f,g ). Notably, the SAT contacts the KS and MAT of the other protomer without interfacing with the connecting LD.
The SAT pseudodimer is arranged at a 35° angle relative to the condensing-region KS-MAT dimer (Fig. 2b ), but the two-fold symmetry axes of KS and SAT are aligned. The N and C termini of the KS and SAT domains are arranged in close proximity to the twofold axis (Fig. 2a) . Although CTB1 is an iPKS, the locations of the N and C termini at opposite ends of the molecule would be compatible with extended connectivity in an assembly line. The only other known structure of a NR-PKS SAT, which was excised as an isolated domain from CazM 18 , reveals a C-terminal linker element that ends in a position similar to that of the SAT-KS in CTB1 despite a lack of sequence conservation in the linker ( Supplementary Fig. 4a,b) . By contrast, the excised loading AT domain of the avermectin modPKS (AVES1) 28 , which features completely different connectivity via an ACP to the downstream KS domain, has a distinct linker architecture resembling the post-MAT linker in PKS and FAS condensing regions ( Supplementary Fig. 4c,d ). Together, these structural comparisons, in agreement with functional domain swaps 19 , support a similar organization among NR-PKS loading domains. The active sites of the loading/condensing region reveal high structural conservation with their closest structural and functional neighbors (Supplementary Table 2a ). The SAT has a conserved Cys-His dyad ( Supplementary Fig. 5a ), which resembles the catalytic Ser-His dyad in AT domains of PKSs and mFASs. Similarly, the active sites of the MAT (Supplementary Fig. 5b ) and KS ( Supplementary Fig. 5c ) are conserved. The KS active sites are connected by a hydrophobic tunnel. The tunnel connection is relatively narrow (Supplementary Fig. 5d ) compared to other PKSs and mFASs connected tunnels, which may be involved in chain-length determination.
Cryo-EM analysis of a trapped ACP-KS post-loading state.
To analyze the impact of substrate loading, we trapped CTB1 SAT-KS-MAT in an initial post-loading state by mechanism-based crosslinking 20, 25 and analyzed it by cryo-EM ( Supplementary Fig. 6 ). In CTB1, the SAT mediates loading of acetyl or, less efficiently, propionyl moieties onto ACP 6 for subsequent transfer to the KS active site cysteine. A Ppant analog linked to a selectively reactive α -bromopropionyl moiety was synthesized (Supplementary Note 1) and enzymatically loaded onto isolated CTB1 ACP2 ( Supplementary  Fig. 6a ), which is functionally equivalent to CTB1 ACP1 ( Supplementary Fig. 6b ) and shares a higher sequence identity (ACP2: 40% vs. ACP1: 30%) with the previously characterized PksA 
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NATure ChemICAl BIology ACP 20, 29 . For crosslinking, the loaded ACP2 was added to a variant of CTB1 SAT-KS-MAT in which the SAT and MAT active sites were mutated to strictly direct crosslinking to the KS (denoted as SAT°-KS-MAT°). Loading of only a single ACP2 to the dimeric SAT°-KS-MAT° was kinetically favored over two-site loading, as previously observed for related NR-PKSs that contain only a single ACP 20 ( Supplementary Fig. 6c ). Using an excess of ACP2 and an extended reaction time, > 90% crosslinking was achieved. Negative-stain EM revealed mostly dimeric particles, whereas cryo-EM grid preparation led to substantial monomerization of SAT°-KS-MAT°= ACP2 ( = indicates chemical crosslink; Supplementary Figs. 6d and 7) . Under optimized conditions, 60% of all particles were observed as intact dimers ( Supplementary Fig. 6e,f) .
Single-particle analysis of dimeric SAT°-KS-MAT°=ACP2 provided a map at 7.1 Å overall resolution and was interpreted by rigidbody and real-space refinement using an all-atom model based on the crystal structure of SAT-KS-MAT and a homology model of ACP2 based on the NMR structure of PksA ACP
29
. Due to the limited resolution and the absence of an authentic high-resolution structure, the analysis for ACP2 is restricted to conserved structural elements (Supplementary Table 1 ; for more details see Online methods). Single-particle processing including reference-free maximum likelihood classification provided a single, predominant conformation of SAT°-KS-MAT° = ACP2 (for details see methods). Although the sample used for grid preparation was > 90% crosslinked to ACP2, only a single ACP position was clearly resolved in an overall asymmetric structure (Fig. 3a-c) . ACP2 is bound in a cleft between the LD and the KS-KS′ dimer. The N-terminal end of helix II in ACP2, which contains the Ppant-analog-bearing DSL motif, points directly toward the KS active site entrance. For ACP interactions in modPKSs, two different interaction sites have been proposed for the transthioesterification from the upstream ACP and elongation with the canonical ACP in modPKSs 27 . Both proposed sites are buried in the KS-LD-AT clefts of the DEBS PKS module five, whereas the ACP in CTB1 sits on top of the KS-LD-MAT cleft and therefore diverges from both proposed models.
At the second KS active site entrance, where no ACP is visualized, the surroundings of the substrate entry tunnel are more disordered ( Supplementary Fig. 8 ). Presuming that ACP2 is still crosslinked to the second site, binding of ACP2 to one KS active site may prevent ordered and competent ACP binding to the second active site by allosteric effects. Such negative feedback is supported by activity assays of 50% crosslinked samples of the related Pks4, which contains a single ACP and exhibits only 20% activity instead of the expected 50% activity relative to a noncrosslinked sample 20 . For the SAT-KS-MAT region, amino acids involved in ACP2 interactions can be identified based on the authentic higher-resolution crystal structure, whereas the limited resolution of the EM reconstruction precludes assignment of interface amino acids in ACP2. The LD core around residue Arg879 and the LD-MAT linker interact with the loop between helix I and II in ACP2. In accord with this proposed interaction, mutations of Arg879 to alanine or glutamate reduce activity in deconstruction experiments for the complete CTB1 PKS (Fig. 3d ,e and Supplementary Fig. 9 ) but do not completely abolish production of nor-toralactone. ACP2 interactions at the KS-KS′ active site entrance (Fig. 3b,c) involve two positively charged residues: Arg461 is strictly conserved in NR-PKSs and Arg658′ is conserved as a positively charged arginine or histidine in the CTB1 clade ( Supplementary Fig. 10a,b) . The mutations R461A or R658A considerably reduce activity, whereas the corresponding charge-inversion mutations to glutamate completely abolish nor-toralactone production, strongly suggesting that the two arginines mediate critical interactions with negatively charged groups in ACP2 ( Fig. 3e and Supplementary Fig. 9 ).
Discussion
Interactions of an ACP with a multienzyme KS domain have previously been resolved in the crystal structure of yeast FAS (yFAS) at 3.1 Å resolution 30 and in the cryo-EM reconstruction of the PikAIII modPKS at 8.6 Å and 7.3 Å resolutions 12 ( Supplementary Fig. 11a -e). Both structures reveal strictly symmetric ACP interactions, but only the heterododecameric yFAS fulfills the distance restraints needed for a productive ACP-KS interaction with solvent-accessible surface (SAS) distances of the ACP Ppant attachment point to the KS active site cysteine of approximately 27 Å ( Supplementary Fig. 11c ,f-i). The position and orientation of ACP relative to KS is conserved between yFAS and the CTB1 NR-PKS despite a completely different integration of the KS domain in a barrel-like scaffold and the presence of an unusual four-helical extension of the canonical ACP domain in yFAS. The corresponding SAS distance in SAT°-KS-MAT°=ACP2 is 28 Å, which is in agreement with a covalently trapped functional interaction ( Supplementary Fig. 11c,f) . The ACP-KS interaction observed in PikAIII, which is nonproductive based on SAS distances ( Supplementary Fig. 11h,i) , however, is considerably different. The ACP docking surface observed in CTB1, and verified by mutant activity assays in deconstruction experiments, is partially blocked in PikAIII due to the divergent location of the LD domain ( Supplementary Fig. 11d,e) .
The cryo-EM solution structure of SAT°-KS-MAT°=ACP2 reveals considerably greater asymmetry than the crystal structure without ACP2, strongly suggesting that the predominant asymmetric conformation derives from ACP2 binding by either an inducedfit or conformational selection mechanism 31 . Relative to the crystal structure, the SATs are translocated individually toward the central KS domains, not as a rigid dimer ( Supplementary Fig. 12a,b) . ACP2 binding causes an upward movement of the proximal LD and MAT regions by 4.4 Å and 8.4 Å, respectively, (Fig. 4 and Supplementary Video 1) resulting in an opening of the interface between the SAT and MAT domains ( Fig. 2d and Supplementary Fig. 12c ). Coordinated with this separation, the proximal SAT domain moves toward the KS by 6.9 Å, substantially enlarging the SAT-KS interface, whereas the second SAT is pushed (by 4.5 Å) against the second pair of KS and MAT domains (Supplementary Fig. 12d ). Because large fragments and domains of various NR-PKSs can be functionally interchanged in deconstruction experiments, coupling of structural changes and catalysis might be representative for many NR-PKSs 7, 10 . Conformational asymmetry and coupling have previously been observed in iteratively acting, fully reducing iPKS 2 and mFASs 5, 32, 33 . The asymmetric conformational states observed in these systems, as well as in SAT°-KS-MAT°=ACP2, are derived by local hinge-bending or shear motions, maintaining the individual domain structures, the key conserved interfaces, and the overall interdomain architecture. For non-iteratively acting modPKSs, however, no information is currently available on functional asymmetry. By contrast, symmetric large-scale conformational transitions that require partial refolding of conserved domains have been visualized by EM analysis of distinct functional states of the modPKS PikAIII on the basis of a divergent condensing region architecture 12, 26 . Functional asymmetry in the interaction of ACP with dimeric enzymatic domains has previously been suggested in the form of a seesaw-type conformational coupling for a bacterial hexameric dehydratase (FabZ) involved in fatty acid biosynthesis 34 that binds ACPs in a 6:3 ratio. However, a stoichiometrically ACP-crosslinked structure of the bacterial dimeric dehydratase FabA demonstrates that asymmetry is not a general feature in related dehydratases even though this structure also revealed increased disorder for the second ACP, as indicated by the crystallographic B factors 25 . A distinct type of persistent structural asymmetry is observed in the iterative actinorhodin type II PKS, in which asymmetry is implemented by heterodimerization of one active KS protomer with a catalytically inactive KS homolog, the chain length factor (CLF) 35 . Iterative elongation is catalyzed only at the KS active site, and the CLF determines maximum chain length by restricting the available volume of the substrate binding tunnel 35 .
Here, the crosslinked interaction of an ACP induces conformational asymmetry across the CTB1 SAT-KS-MAT loading/condensing region. Binding of an early elongation intermediate, mimicked here by the α -bromopropionyl moiety, may cause local asymmetry around the KS active sites. However, the observed overall asymmetry is more plausibly explained by binding of the ACP, which directly connects the KS active site to the surrounding domains via the LD, which is part of the ACP binding interface.
Substrate elongation in NR-PKSs occurs rapidly, and reactive intermediates remain bound in the active site tunnel of the KS, as suggested by the absence of detectable ACP-bound chain elongation intermediates in PksA 17 . After initial loading, however, the ACP shuttles between the KS and the MAT active site for delivery of malonyl extender units. Presuming that ACP binding is linked to overall asymmetry in the SAT-KS-MAT region, productive binding of an extender-unit-charged ACP (malonyl-ACP) to one KS active site would disfavor binding to the other KS active site in every elongation cycle. Product elongation by the dimeric KS would occur with alternating asymmetric states that are analogous to a V-twin engine, favoring substrate loading by the MAT on one side and elongation by the KS on the other side of the dimer (Fig. 4 and Supplementary Video 1). Considering that the ACP binding sites are located proximal to the attachment points for the downstream modification (PT) and release (TE) domains, ACP could plausibly contribute to a coordination of substrate shuttling and overall product formation analogous to conformational coupling 2 and large scale rearrangements 12, 26 observed in modifying regions of other PKSs. However, further analysis will be required to dissect the relative contributions of substrate loading and ACP interaction on asymmetry in iterative and modular PKSs.
Understanding the architectures and dynamic properties of PKSs remains a central challenge in natural product research. Although all canonical types of PKS domains have been studied in detail in isolation, understanding substrate loading and transfer, as well as the functional integration of individual domains into large multienzymes or even assembly lines remains a challenge. Our analysis of CTB1 SAT-KS-MAT now reveals the organization of an integrated loading architecture in a PKS and suggests a mechanism for conformational coupling between the two protomers of the dimeric PKS promoted by substrate loading to KS. These results provide an important step toward a comprehensive understanding of conformational coupling in PKS multienzyme function and afford critical insights for the dissection and re-engineering of initial substrate loading for polyketide production. 
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Methods
Cloning. Plasmids used in this study were assembled using standard protocols. CTB1 SAT°-KS-MAT° was generated by site-directed introduction of the mutations C119A and S1010A. All plasmids used in this study are summarized in Supplementary Table 3 . The plasmids for expression of wild-type CTB1 SAT-KS-MAT (pECTB1-NKA6), PT (pECTB1-PT), and TE (pECTB1-TE) have been previously described 24 . Primers used for assembly of new plasmids in this study are detailed in Supplementary Table 4. All expression constructs were prepared and maintained in E. coli BL21(DE3). Cut sites for CTB1 ACP2 deconstruction were chosen based on the PksA ACP solution structure 29 . CTB1 ACP2 was cloned as an N-terminal Thrombin-cleavable His 6 -tagged construct to allow differential purification throughout the crosslinking process. The desired gene sequence was amplified by PCR from pECTB1-ACP (tandem ACP, previously described) 24 using CTB1-ACP2-5 and CTB1-ACP2-stop-3, and ligated into pET-28a at NdeI and NotI sites using T4 DNA ligase. Active site mutations for selective crosslinking were introduced into pECTB1-NKA6 by Gibson assembly 36 of PCR-amplified fragments using standard protocol, giving pECTB1-SKM-C119A-S1010A. Mutations to CTB1 SAT-KS-MAT for interface validation were introduced via Gibson assembly in the same manner. Assembled plasmids were screened by restriction digestion and sequences confirmed by the Johns Hopkins Synthesis and Sequencing Facility (Baltimore, MD). Sequencing revealed the point mutation T321A (compared to Uniprot Q6DQW3) in all SAT containing constructs.
Protein expression and purification for crosslinking and interface validation.
Proteins were expressed as His 6 -tagged constructs in E. coli BL21(DE3). One liter Terrific Broth cultures supplemented with 25 μ g/mL kanamycin (GoldBio) were inoculated with overnight starter cultures and grown at 37 °C with shaking at 250 r.p.m. until OD 600 reached 0.7. Cultures were cold-shocked in ice water for 1 h before induction with 0.5 mM isopropyl-β -d-thiogalactopyranoside (IPTG; GoldBio). Expression was carried out at 19 °C with shaking at 250 r.p.m. for approximately 16 h. Cells were harvested by centrifugation at 4000 × g for 15 min and flash frozen in liquid nitrogen for storage at − 80 °C.
Cell pellets were thawed in lysis buffer A (50 mM potassium phosphate, pH 8, 300 mM NaCl, 10% (v/v) glycerol) and lysed by sonication. Lysate was cleared by centrifugation at 27,000 × g for 25 min. The resulting supernatant was batch bound to Co 2+ -TALON resin (Clontech) at 4 °C, typically for 1 h. The protein-bound resin was applied to a gravity-flow column and washed and eluted with lysis buffer A containing increasing concentrations of imidazole (0-100 mM), as directed by the manufacturer. Fractions containing the protein of interest were pooled and dialyzed against the appropriate buffer (50 mM Tris pH 7.5, 5% (v/v) glycerol unless otherwise indicated) at 4 °C. For dialysis of CTB1 SAT°-KS-MAT°, 1 mM DTT was included to maintain the KS active site cysteine in its reduced form. If necessary, the protein was concentrated in Amicon Ultra centrifuge filters (Millipore). Protein concentration was quantified based on absorbance at 280 nm on a Cary 50 UV-Vis spectrophotometer and extinction coefficients calculated using Expasy ProtParam (Supplementary Table 3 ). CTB1 ACP1 concentration was determined in triplicate by Bradford assay (Bio-Rad) using bovine serum albumin as a standard.
Proteolysis of tag from CTB1 ACP2-His. To facilitate separation of ACP2 from both crosslinker loading reactions and crosslinking reactions, the N-terminal His 6 -tag was removed by thrombin proteolysis using a Thrombin CleanCleave Kit (Sigma Aldrich). The thrombin agarose resin was washed with reaction buffer (50 mM Tris pH 8, 10 mM CaCl 2 ) and conditions were optimized as recommended by the manufacturer. Complete cleavage was achieved using approximately 100 μ L thrombin agarose resin per 50 mg CTB1 ACP2 at 2 mg/mL CTB1 ACP2 in reaction buffer. Reactions were rotated for 3 h at 25 °C. Cleavage was monitored by SDS-PAGE and confirmed by MALDI-TOF (Bruker Auto Flex III). Cleaved CTB1 ACP2 was isolated by brief centrifugation at 500 × g to pellet the thrombin resin and dialyzed in 50 mM Tris pH 7.5, 5% (v/v) glycerol at 4 °C.
Expression and purification of CTB1 SAT-KS-MAT for crystallization.
C-terminal hexahistidine (His 6 ) tagged CTB1 SAT-KS-MAT (pECTB1-NKA6, aa 1-1293) was overexpressed with Streptomyces chaperonins (pETcoco-2A-L1SL2 plasmid) 37 in E. coli BL21(DE3) pRIL. Cells were cultured in 2 × YT medium, supplemented with 0.5% (v/v) glycerol, NPS (25 mM (NH 4 ) 2 SO 4 , 50 mM KH 2 PO 4 , 50 mM Na 2 HPO 4 ), kanamycin (100 μ g/mL), chloramphenicol (34 μ g/mL), and ampicillin (100 μ g/mL). An expression culture (1.5 L) was inoculated (1:20) , grown at 37 °C for 2 h, cooled to 20 °C, and induced with IPTG (0.1 mM) at an OD 600 of 1.0. Cells were harvested after 12 h by centrifugation (7000 × g) and resuspended in lysis buffer B (50 mM HEPES pH 7.4, 200 mM NaCl, 2.5 mM MgCl 2 , 40 mM imidazole, 10% (v/v) glycerol, 5 mM β -mercaptoethanol), supplemented with protease inhibitors (200 μ M phenylmethylsulfonyl fluoride, 20 μ M bestatin, 4 μ M E64, 2 μ M pepstatin A, 20 μ M phenantrolin, 2 μ M phosphoramidon) as well as DNase I, RNase A, and lysozyme. Cells were placed on ice and lysed by sonication. The lysate was cleared by centrifugation (100,000 × g for 30 min) and immobilized by metal-affinity chromatography on a 25 mL Ni-affinity column (GenScript) pre-equilibrated with lysis buffer B. Unbound protein was eluted with five column volumes (CV) of HisA buffer (50 mM HEPES pH 7.4, 200 mM NaCl, 2.5 mM MgCl 2 , 40 mM imidazole, 10% (v/v) glycerol, 5 mM β -mercaptoethanol, protease inhibitors). The sample was eluted with a linear gradient to 100% HisB buffer (50 mM HEPES pH 7.4, 500 mM imidazole, 50 mM NaCl, 10%(v/v) glycerol, 2.5 mM β -mercaptoethanol, and protease inhibitors) and directly loaded on a strong anion-exchange column (PL-SAX 4000 Å, 10 μ m, Agilent). The protein was eluted with a linear gradient from 0% AIC-A (50 mM HEPES pH 7.4, 50 mM NaCl, 10% (v/v) glycerol, 2.5 mM β -mercaptoethanol) to 100% AIC-B (50 mM HEPES pH 7.4, 1 M NaCl, 10% (v/v) glycerol, 2.5 mM β -mercaptoethanol). The protein was concentrated with Amicon Ultra centrifuge filters (Millipore) and subjected to size-exclusion chromatography (SEC; Superdex 200 16/60, GE Healthcare) using 20 mM HEPES pH 7.4, 250 mM NaCl, 5% glycerol (v/v), 1 mM dithiothreitol. Protein-containing fractions were pooled and concentrated in Amicon Ultra centrifuge filters (Millipore) to 10-15 mg/mL and frozen in liquid nitrogen.
Synthesis of α-bromopropionyl aminopantetheine. For full synthetic details and compound characterization see Supplementary Note 1.
Phosphorylation of α-bromopropionyl aminopantetheine. α -bromopropionyl aminopantetheine was phosphorylated enzymatically under the following conditions: 0.25 mg/mL PanK (pantothenate kinase), 2 mM α -bromopropionyl aminopantetheine, 5 mM ATP, 20 mM KCl, 10 mM MgCl 2 , 50 mM Tris pH 7.5 at room temperature for approximately 20 h. Complete phosphorylation was confirmed by UPLC-ESI-MS (Waters Acquity/Xevo-G2, negative ion mode). All protein was removed from the reaction with a 3 kDa MWCO Amicon Ultra centrifuge filter (Millipore). The flow-through was flash frozen in liquid nitrogen and lyophilized to dryness. The resulting white powder was resuspended in 5% aqueous acetonitrile. α -bromopropionyl aminopantetheine was HPLC purified on an Agilent 1100 equipped with a Kinetex C18 semi-prep column (250 × 10 mm, 5 μ , Phenomenex) using the following method at 4 mL/min: hold 5% solvent A/95% solvent B for 3 min, 5-35% solvent A over 17 min, 35-95% solvent A over 5 min, followed by re-equilibration to 5% solvent A, where solvent A is acetonitrile + 0.1% trifluoroacetic acid and solvent B is 0.1% trifluoroacetic acid. Purity and identity of the isolated compound was confirmed by UPLC-ESI-MS using a Waters Acquity/ Xevo-G2 in positive ion mode as above, and the pooled fractions were lyophilized to dryness.
Loading of ACP2 with α-bromoacyl crosslinker. α -bromopropionyl aminophosphopantetheine was adenylated and subsequently loaded onto CTB1 ACP2 in a one-pot enzymatic reaction under the following conditions: 0.5 mM α -bromopropionyl aminophosphopantetheine, 0.5 mg/mL PPAT (phosphoribosyl pyrophosphate amidotransferase), 5 μ M Sfp (surfactin 4'-phosphopantetheinyl transferase), 0.5 mM CTB1 ACP2, 5 mM ATP, 10 mM MgCl 2 , 20 mM KCl, 50 mM Tris pH 7.5, 10% glycerol. Reactions were run at 22-24°C and monitored by MALDI-TOF (Bruker AutoFlex III). Once loading was complete, the His-tagged Sfp and PPAT were separated from untagged CTB1 ACP2 by passing the reaction solution through an equilibrated Co 2+ -TALON column (Clontech) and recovering the flow-through. Additionally, any unreacted crosslinker was removed by repeated concentration and dilution with a 3 kDa MWCO Amicon Ultra centrifuge filter (Millipore). Complete removal of free crosslinker was confirmed by UPLC-ESI-MS analysis.
Crosslinking of CTB1 SAT°-KS-MAT° to ACP2. CTB1 SAT°-KS-MAT° was combined with 20-fold excess CTB1 ACP2 bearing the α -bromoacyl crosslinker in 50 mM Tris pH 7.5, 10% glycerol (v/v) at room temperature for 1 h. Crosslinking was monitored by SDS-PAGE and found to be approximately 95% complete after 1 h. Crosslinked SAT°-KS-MAT°=ACP2 was separated from remaining free SAT°-KS-MAT° by anion exchange chromatography. Q-Sepharose Fast Flow resin (GE Healthcare) was equilibrated with 50 mM Tris pH 7.5 and 10% glycerol, and the crosslinking reaction mixture was applied to the column. SAT°-KS-MAT° and SAT°-KS-MAT°=ACP2 were separated using a gradient of potassium chloride from 0-500 mM. To remove free ACP2 from the crosslinked protein, fractions containing SAT°-KS-MAT°=ACP2 were pooled and applied to an equilibrated Co 2+ -TALON column. ACP2 was removed in the flow-through, and pure SAT°-KS-MAT°= ACP2 was eluted with a gradient of imidazole from 2-100 mM.
In vitro enzymatic reactions. CTB1 SAT-KS-MAT (wild-type and mutants of proposed interface residues), PT, ACP1, ACP2, and TE were purified as described above and dialyzed into 100 mM potassium phosphate pH 7 and 10% glycerol. ACP1 and ACP2 were activated enzymatically with CoA for 1 h at 25 °C under the following conditions: 2 μ M Sfp, 0.5 mM CoA, 10 mM MgCl 2 , 200 μ M ACP2, 100 mM potassium phosphate pH 7, and 10% glycerol.
To compare the biosynthetic competency of ACP1 and ACP2, specifically the ability of the ACP to interact with KS, minimal PKS reactions containing only SAT-KS-MAT and ACP were performed. ACP1 and ACP2 concentrations were determined in triplicate by the Bradford assay using bovine serum albumin as a standard. 10 μ M SAT-KS-MAT was combined with 10 μ M ACP1, 10 μ M ACP2, or 5 μ M of each ACP in assay buffer (100 mM potassium phosphate pH 7, 10% glycerol, 1 mM TCEP). Reactions were initiated by addition of 0.5 mM acetyl-S-Nacetylcysteamine (SNAC) and 2 mM malonyl-SNAC and incubated for 4 h at 25 °C.
The
Product profiles of each enzyme mutant were analyzed on an Agilent 1200 equipped with a Prodigy ODS3 analytical column (4.6 × 250 mm, 5 μ m, Phenomenex). 100 μ L injections were separated by a bisolvent method at 1 mL/min: 5-85% solvent A over 40 min; 85-95% solvent A over 10 min; re-equilibrate to 5% solvent A over 10 min (where solvent A is acetonitrile + 0.1% formic acid and solvent B is 0.1% formic acid). Chromatograms were recorded at 280 nm, and UV-vis spectra were recorded over a range of 200-800 nm. High-resolution mass data were collected on a Waters Acquity/Xevo-G2 in positive ion mode. Previously characterized CTB1 derailment products were identified by their UV-Vis spectrum and exact mass 24 . For CTB1 interface validation, the full PKS was reconstituted with each SAT-KS-MAT mutant under the following conditions: 10 μ M CTB1-SAT-KS-MAT, 10 μ M PT, 10 μ M ACP2, and 10 μ M TE were combined in assay buffer. Reactions were initiated by addition of 0.5 mM acetyl-SNAC and 2 mM malonyl-SNAC and incubated for 4 h at 25 °C. Reactions were extracted and analyzed by HPLC as above. and 56% solvent content were collected at the Swiss Light Source (SLS, Villigen, Switzerland) at beamline X06SA, a temperature of 100 K and a wavelength of 1.000 Å. Data reduction was performed using XDS and XSCALE 38 , and data were analyzed using phenix.xtriage 39 . Table 1a and Supplementary Fig. 1 ).
Electron microscopy sample preparation and data collection. Initial sample quality was evaluated by conventional negative-stain EM. Initial cryo-EM analysis revealed a monomer-dimer equilibrium, which has previously been observed for PKS and FAS fragments 2, 12, 14, 44, 45 . Buffer conditions were optimized by analyzing SAT-KS-MAT by analytical size-exclusion chromatography (SEC; 4.6/250 Superose 6 Increase, GE Healthcare) at a flow rate of 0.1 mL/min followed by grid preparation and testing of the maximal achievable particle concentration. The results indicated a fast equilibrium and a mostly dimeric species in low-salt buffer (20 mM Tris pH 7.4, 50 mM NaCl, 2.5 mM tris(2-carboxyethyl)phosphine (TCEP); Supplementary Fig. 6e ). For cryo-EM, crosslinked sample was concentrated to 15-16 mg/mL, applied to analytical SEC and collected in fractions of 50 μ L. For grid preparation, 4 μ L of individual fractions were applied to glow discharged (30 s) lacey carbon grids (300 mesh, copper), immediately blotted for 2 s, and plungefrozen in liquid ethane using a Vitrobot (FEI, Vitrobot III). An incubation step was omitted because of fast adsorption of the particles to the carbon. The integrity of the crosslinked sample was analyzed by denaturing PAGE of the remaining sample after grid preparation (Supplementary Fig. 6f ).
Grid quality was analyzed using a Philips CM200 FEG cryo-transmission electron microscope, operated at an acceleration voltage of 200 kV. Optimal conditions were identified for peak fractions diluted to 270 μ g/mL in a tradeoff between low particle density (approximately 70 particles per micrograph), monomer formation and particle adsorption to carbon. Final data was collected using a Titan Krios electron microscope (FEI) operated at 300 kV, a GIF Quantum LS imaging filter (Gatan) and a K2 Summit (Gatan) operating in counting mode. Images were acquired at 0.8-4.5 μ m defocus and a nominal magnification of 105,000× , corresponding to a pixel size of 1.326 Å (Supplementary Table 1b) . Movies were collected with a total dose of approximately 90 e − /Å 2 per 18 s exposure, fractionated over 60 frames.
EM data processing and analysis. Drift correction of dose fractionated frames 46 was performed using Zorro 47 and global contrast transfer function (CTF) parameters were determined using CTFFIND4.1 (ref. 48 ). Particles were picked from aligned dose-filtered averages using the swarm semi-automated procedure as implemented in e2boxer.py 49 , followed by extraction from unfiltered averages using Relion-2 (ref. 50 ) and local CTF parameter refinement using Gctf v1.06 (ref. 51 ). Single-particle analysis included several rounds of reference-free maximum a posteriori-2D classification 50 to remove junk particles and monomers, revealing a clearly distinguishable shape; this could be reconstructed at low resolution ( Supplementary Figs. 6d and 7a) . For reconstruction of the dimeric, crosslinked SAT°-KS-MAT°=ACP, an initial volume was generated using e2initialmodel. py 49 and low-pass filtered to 50 Å. Exhaustive global followed by local referencefree 3D classification and alignment without symmetry were applied, yielding highly similar classes that were combined in a consensus refinement before movie refinement and particle polishing, as implemented in Relion-2 (ref. 50 ). Parameters for B-factor fitting as a function of movie frames have been carefully examined, as well as the different number of frames in the particle movie stacks. At this stage all 60 frames were included in the weighted particle movie stacks, as no substantial difference between inclusion of different amounts of frames per movie could be identified after applying weighting. Another round of 2D and 3D classification yielded three almost-identical volumes that were refined as individual classes and in all possible combinations of classes. The combination of two classes ( Supplementary Fig. 7a ) resulted in a slightly improved model at 7.3 Å resolution (25,107 particles) in comparison to all three classes at 7.5 Å (44,859 particles) . For the refinement of the final map at 7.1 Å resolution, weighted particle averages of 27 movie frames were used, corresponding to a total dose of 41 e − /Å 2 . All reported resolution estimates are based on the 0.143 threshold criterion of the Fourier Shell Correlation (FSC) 52 between two halves of the data set refined independently in RELION-2, after accounting for correlations introduced by masking 53 . Throughout all refinements in Relion-2 (ref. 50 ), particles were grouped by k-mean clustering of their CTF parameters with a minimum of 50 particles per group. The alignment was not influenced by a preferred orientation 54 ( Supplementary Fig. 7b,c) , which was assessed by reducing the number of particles per angular sampling group to the mean of all groups by random subset deletion in four independent refinements. Later refinements were carried out using a soft mask and solvent-corrected FSC during the refinement 53 . Final maps were sharpened with a sharpening B factor of − 350 Å 2 . Local resolution was calculated with ResMap 55 and indicated higher resolution for secondary structure elements in the center of the particle ( Supplementary Fig. 7d,e) . Therefore, masked 3D classification and refinement after signal subtraction 56 was carried out, resulting in slightly improved resolution but no substantial differences in the electron density map. Map generation from coordinates as well as filtering and file type conversion was done using EMAN2 tools 49 . For analysis, map transformations were applied using the CCP4 tool maprot 57 . Maps were resampled using UCSF Chimera 58 , and difference maps were calculated by Python Numpy and MRCZ 59 .
Cryo-EM structure refinement and modelling. Modelling of the cryo-EM structure was started by rigid body fitting of individual domains of the CTB1 SAT-KS-MAT crystal as well as of an ACP2 homology model in Coot 43 . The orientation of ACP2 could be unambiguously determined based on steric requirements of the Ppant attachment site (DSL motif), a continuously connected density between ACP2 helix II and the KS active site entrance, and additional density features which can be explained by loop regions of the homology model. The model for CTB1 ACP2 was generated using SwissModel 60 based on PksA ACP 29 , which shares 40% sequence identity and can be functionally replaced with the CTB1 tandem ACPs in in vitro assays 7, 10 . Initial B factors of the model were scaled relative to B factors of atomic displacement parameter (ADP) refined crystal structures in the PDB at similar resolution. Prior to map-based realspace refinement, the model was protonated using phenix.reduce and geometry minimization with secondary structure restraints and reference coordinate restraints was applied using phenix.geometry_minimization 39 . Afterwards global minimization and ADP refinement with reference structure restraint was carried out against the unsharpened cryo-EM map in phenix.real_space_refine 39 . Reference structure and nonbonded distance restraint weights were carefully monitored and optimized. As the local resolution around the resolved ACP2 is not sufficient to unambiguously interpret possible conformational changes of loop regions relative to the isolated PksA ACP NMR structure, the loop regions were excluded from the final model after all atom refinement, without affecting model statistics (Supplementary Table 1b ). The resulting model contained the regions corresponding to the canonical ACP four helix bundle (residues: 1782-1796, 1816-1828, 1839-1842, 1846-1854) and was validated using phenix.molprobity 39 with Ramachandran plot statistics of "favored/outliers": 96.47%/0.12%. A position for a second crosslinked ACP2 could not be undoubtedly resolved in any intermediate or final EM map. The sample has been analyzed after grid preparation and is > 90% crosslinked (Supplementary Fig. 6f ).
Due to residual noise around the putative second ACP2 binding site, the presence of a second ACP2 in a mostly disordered state without a solid interface, tethered only by covalent crosslinking (Supplementary Fig. 8a,b) , cannot be strictly excluded. However, we cannot exclude the possibility that effects of selective adsorption of partially or fully crosslinked SAT°-KS-MAT° = ACP2 or those of selective destabilization under grid preparation also contribute to selective imaging of a single-crosslinked state with low population in the sample used for grid preparation.
Structure analysis and visualization. Related structures were identified using PDBeFold (20% query/10% target) 61 , and interfaces were analyzed using QtPISA v2.1.0 (ref. 57 ). Transformations and coordinate manipulations were carried out using CCP4 tools and MOLEMAN 62 . Bias-removal for crystallographic F o -F c omit maps was achieved by applying a random perturbation to coordinates (Δ 0.2 Å) and B factors (Δ 20% of the mean overall B factor) with MOLEMAN2 (ref. 62 ) before refinement. C α -r.m.s. deviation between domains of the crystal and cryo-EM structure were calculated using LSQMAN 63 . Structures of PikAIII were modeled according to Dutta et al. 12 using Chimera
58
. Solvent-accessible surface distances (SAS) between C α atoms of ACP phosphopantetheinylation and KS active site residues were calculated using Xwalk 64 . Figures, movies and plots were generated using Pymol (Schrodinger, v1.8.6.0) and Python.
Sequence analysis. Sequence alignments were generated using Clustal Omega 65 . A Phylogenetic tree was generated using the neighboring joining algorithm in Geneious (Biomatters Limited, v8.1.6).
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